Lisinopril Tablet
Product Images NDC 68071-5098

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 68071-5098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pd (68071 5098 9)

Pd (68071 5098 9)
This is a pharmaceutical label for Lisinopril tablets of 20mg, manufactured by NuCare Pharmaceuticals and packed by S2i83e. Each tablet is yellow in colour and has "WATSON" and "*408" markings on one side. The tablets contain Lisinopril, USP, an angiotensin-converting enzyme inhibitor prescribed for the treatment of hypertension, heart failure and other cardiovascular conditions. The lot number of the tablets is 000000, and the tablets are packaged in a bottle containing 90 tablets. The National Drug Code (NDC) for the tablets is 68071-5098-9, and the expiration date is not available. The label warns to keep the tablets away from children and store them at a temperature between 68-77°F. Contact a doctor immediately if side effects are experienced.*
FDA Label Image

Lisinopril, Usp Is An Oral Long-acting Angiotensin Converting Enzyme (ace) Inhibitor. Lisinopril, A Synthetic Peptide Derivative, Is Chemically Described As (s)-1-[n2-(1-carboxy-3-phenylpropyl)-l-lysy (Image 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.